benzofuroxan has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendonça-Junior, FJ; Scotti, L; Scotti, MT | 1 |
| Duan, Y; Huang, Y; Mao, J; Wang, X; Xu, W; Zhang, H; Zhang, J | 1 |
2 other study(ies) available for benzofuroxan and Neoplasms
| Article | Year |
|---|---|
Editorial (Thematic Issue: Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part II).
Topics: Alzheimer Disease; Anti-Infective Agents; Benzoxazoles; Chemistry, Pharmaceutical; Drug Discovery; Humans; Neoplasms; Neuroprotective Agents; Oxadiazoles; Polypharmacology | 2017 |
Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
Topics: Animals; Antineoplastic Agents; Benzoxazoles; Binding Sites; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Hydroxamic Acids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Molecular Docking Simulation; Neoplasms; Neovascularization, Physiologic; Nitric Oxide; Pyrrolidines; Structure-Activity Relationship | 2018 |